Attys Agree to $143 Million Fee Split in $2.3 B Avandia MDL

Plaintiffs’ attorneys on Thursday filed a plan in Pennsylvania federal court to split $143 million to resolve a fee dispute in what could be a $2.3 billion settlement in a massive multidistrict litigation (MDL) over GlaxoSmithKline’s alleged failure to warn consumers about health risks related to its diabetes drug Avandia.
Law360